Apelka 5 mg/mL oral solution for cats

Apelka is a specialized veterinary pharmaceutical used primarily to treat hyperthyroidism in cats. The medication contains the active ingredient thiamazole (methimazole), which helps stabilize thyroid hormone levels. It is presented as an oral solution, making it easier for pet owners to administer precise doses compared to traditional tablet forms.

The product is part of the animal health portfolio of Boehringer Ingelheim, a major German pharmaceutical company. Boehringer Ingelheim has a long-standing history in the research and development of both human and animal health products. The brand Apelka was developed within their veterinary division to provide a more flexible dosing option for feline patients.

Today, Apelka is manufactured and distributed globally by Boehringer Ingelheim Animal Health. While the company operates many facilities, its primary production and high-level research for such specialized veterinary products are centered in Germany. The brand remains under the ultimate ownership of the parent company, Boehringer Ingelheim, which is one of the world's largest private pharmaceutical firms, headquartered in Ingelheim am Rhein.